About Predictive Therapeutics
Predictive Therapeutics is a clinical stage oncology company, with a focus on immunotherapy. We seek to acquire undervalued late stage assets for clinical development. Our goal is to unlock the potential of these promising cancer therapies in order to bring effective and safe drugs to patients.
Would you like to learn more about working with Outcome Capital or discuss your specific needs?